The Under-Eye Patch Packaging Fiasco: What Fenty Skin, Glow Recipe and Huda Beauty Are Actually Launching

The beauty internet has a new product-development mystery: why are Fenty Skin, Glow Recipe and Huda Beauty suddenly showing under-eye patches that appear to be dispensed through the same twist-and-slice packaging idea?

It is an excellent story because the surface-level drama is easy to understand, while the technical reality is much more interesting. The shared object is not just a cute component. It is a delivery system, a preservation problem, a dose-control problem, a claims problem and, potentially, an intellectual-property question.

This is a technical read of the launch moment, not a verdict that one brand copied another. Product-development timelines are private, the complete INCI lists are not yet public for all three products, and similar packaging can come from parallel development or a shared component platform.

What actually happened

On 22 September 2026, Cosmetics Business reported that Fenty Skin, Glow Recipe and Huda Beauty had all teased hydrogel eye-patch products using a grinder-style delivery mechanism. Fenty’s earlier teaser showed a container being twisted while a patch emerged. Within roughly a day, Glow Recipe footage and creator footage of the Huda Beauty product made the comparison unavoidable.

Fenty then leaned into the conversation with a social post showing the products in a Spider-Man-style pointing meme. That response matters because the brand itself acknowledged the visual sameness instead of pretending consumers were not seeing it. Huda Kattan commented on the post, while the creators showing Glow Recipe’s product explicitly noted that similar packaging does not prove that the contents are the same.

The timing looks like a three-brand pile-on. It is not necessarily a three-day development story. A cosmetic product with a new component, a hydrogel substrate, a preservation system, stability work, artwork and a launch plan is normally in development long before the teaser appears. Social launch order is evidence of posting order, not evidence of who formulated or commissioned the idea first.

The real innovation is a system, not a patch

Under-eye patches are already a mature category. The new part here is the way the product is served. A conventional hydrogel eye mask is usually supplied as pre-cut pairs in a jar, tray or individual sachet. The fresh-sliced concept moves part of the cutting and dosing experience into the primary pack.

That changes the product brief. The component now has to do several jobs at once:

• Protect a high-water formula and its hydrogel substrate through shelf life.
• Release a consistent patch without tearing, folding or sticking to the mechanism.
• Give the user a satisfying twist without requiring excessive force or precision.
• Keep the unused product protected after each dose.
• Make the novelty legible on camera and on shelf.

In other words, the packaging is part of the ritual and part of the product claim. “Fresh sliced” is not only a visual description. It implies controlled release, a cleaner experience and a reason to believe the patch is being served differently from a commodity jar.

What is actually in the formula?

The honest answer is that the full comparison cannot be made yet. A product name tells us the intended story, not the complete composition. Glow Recipe’s official page names exopeptide, caffeine, brightening and depuffing in the product title. Fenty’s name points toward dew, plumping, hydration and fresh-sliced delivery. The Huda Beauty product has appeared in unreleased-product footage, but the public coverage does not provide a verified full INCI list.

That limitation is exactly why a technical analysis is more useful than a quick “same formula” accusation. Hydrogel is a format. It is not one universal material and it is not an active ingredient.

1. The hydrogel matrix

A hydrogel patch is a water-rich polymer network that holds a serum-like phase in a flexible, coherent sheet. The matrix has to stay wet enough to feel cooling and comfortable, but strong enough to be cut, handled, transported and placed under the eye without becoming a torn jelly.

Typical formulation levers can include natural or synthetic gelling polymers, humectants, plasticising agents, film formers and texture modifiers. The exact choice affects wet strength, elasticity, tack, serum release, shrinkage, tear resistance and how well the patch stays in place. Two products can both be called hydrogel and still feel materially different on skin.

2. The serum phase

The liquid held by the patch may be designed around humectancy, cooling, slip, soothing or a short-contact treatment story. Glycerin, glycols, betaine and hyaluronic-acid materials are common design options for water binding, but their use level and combination change the sensory result. Too much humectancy can become tacky or uncomfortable in humidity. Too little can make the patch feel dry before the intended wear time is over.

There may also be peptides, caffeine, niacinamide, botanical extracts or other brightening and comfort ingredients. Their presence alone would not establish the finished-product claim. The formula still needs the right concentration, stability, skin tolerance, use instructions and evidence route.

3. Preservation and the eye-area constraint

A water-rich, repeatedly accessed product creates a serious microbiological design question. The team has to control the formula, the substrate, the fill process, the cutting path and the user’s exposure to the unused product. A clever dispenser does not remove the need for preservative efficacy work, stability testing or a realistic contamination assessment.

The eye area also leaves less room for sensory mistakes. Sting, fragrance, essential oils, pH, active choice, residual processing aids and migration toward the eye all matter. “It feels cooling” is a sensory target. It is not a substitute for appropriate safety and tolerance assessment.

Why the component is doing more than looking cute

From the public footage, the user twists the pack and a cut patch appears. The internal architecture is not disclosed, so it would be irresponsible to pretend we know whether each brand is using the same substrate roll, a cartridge, a folded web, a molded gel format or a supplier’s licensed mechanism.

But any serious development team would need to answer the same component questions:

• Cut geometry: Is the patch shape consistent, and does the cut edge feel smooth on delicate skin?
• Dose control: Is each patch the same mass and serum loading, or is the user receiving an approximate dose?
• Actuation: What torque, friction and number of turns are acceptable for the target user?
• Barrier performance: How does the closed pack limit water loss, oxygen exposure and contamination between uses?
• Material compatibility: Does the formula extract, swell, stain or stress any contact material, adhesive, seal or cutting surface?
• Shipping: Does heat, cold, vibration or altitude change the patch, the serum distribution or the dispensing force?
• Manufacturing: Can the component be filled, assembled, sealed and inspected at the intended scale without creating an unacceptable scrap rate?

This is why packaging and formula cannot be separated until the end. A hydrogel that performs beautifully in a tray may tear at a cutter. A cutter that works with one gel strength may crush another. A formula that survives a jar may lose water or interact with a new material in a dispensing cartridge.

Why might three brands show up with the same idea?

There are several plausible explanations, and more than one can be true:

• A shared component platform: A packaging supplier may have shown multiple brands the same twist, slice or dispensing architecture. A common component can carry different artwork, gel formats, formula systems and claims.
• Parallel development: Several teams may have identified the same consumer desire for a more visible, more hygienic and more content-friendly eye-mask ritual.
• Trend compression: K-beauty packaging innovations can move quickly through supplier networks, trade shows, creator seeding and retailer conversations.
• Competitive imitation: It is possible in any crowded category, but the public evidence available right now does not prove that explanation.

Trade coverage also points out that Wonder Bath has already marketed a slicing serum mechanism. That makes the debate more nuanced. The question may not be who invented the broad idea of slicing a skincare product. It may be who commissioned a particular component, who owns a specific mechanism or appearance, and how much of the final product is genuinely differentiated.

Launch order is a social-media fact. It is not a product-development timeline.

There may be patent, design-right, trade-dress, licensing or supplier-confidentiality questions here. Those are questions for an intellectual-property professional with access to the actual component drawings, agreements and filing history. A screenshot comparison is not enough to reach a legal conclusion.

The claims problem hiding inside the novelty

Packaging can make a product feel innovative before the customer has evaluated the formula. That is powerful, but it creates a temptation to let the visual mechanism carry claims the product has not earned.

For a hydrogel eye patch, separate the claim layers:

• Format truth: a hydrogel patch is supplied through a twist-operated or fresh-sliced component.
• Immediate sensory result: the patch feels cool, comfortable, smooth or well-fitting during use.
• Visible or instrumental result: the product temporarily improves the appearance of puffiness, dryness, fine lines or dullness under a defined protocol.
• Ingredient rationale: caffeine, peptides, humectants or other ingredients are included for a reason supported by suitable evidence.

These are not interchangeable. In the United States, the FDA says cosmetic claims must be truthful and not misleading, and that claims about treating disease or affecting the structure or function of the body can move a product into drug territory. Market-specific review is still needed for the words, visuals, directions and product positioning you actually intend to use.

Mini case study: if a founder brought this brief to a lab

Imagine a founder says: “I want the excitement of a fresh-sliced under-eye patch, but I do not want a copy of what is already online.” That is not yet a formulation brief. A better development path would look like this:

1. Define the product job. Is the product for pre-makeup cooling, morning depuffing, overnight hydration, travel recovery or a visible social ritual? Choose one primary job before choosing the active list.
2. Write the anti-benchmark. No sliding, no fragrance near the eye, no dripping serum, no single-use waste, no sticky finish or no difficult twist can be more useful than another adjective pile.
3. Separate the three systems. Specify the hydrogel matrix, the serum phase and the active story as related but distinct decisions. That lets the laboratory change the gel strength without accidentally changing the product promise.
4. Request the component file. Ask for drawings, material declarations, fill path, seal and closure details, MOQ, tooling, lead time, decoration options, dose assumptions and confirmation of any licensing or exclusivity constraints.
5. Test the product in the real pack. Measure patch mass, cut consistency, actuation force, wear time, tear resistance, leakage, residue, package interaction, microbial performance and stability under the intended shipping conditions.
6. Build the claims route before launch. Decide which statements are sensory, which are visible-result claims, which need instrumental measurement and which need consumer perception work on the finished product.

The outcome is not merely “a patch that comes out of a grinder.” It is a product with a defensible job, a controlled formula, a compatible component, a credible claim and a development file a lab can actually use.

What founders and labs should take away

• A shared package does not automatically mean a shared formula.
• A different formula does not automatically make a copied component strategically safe.
• Hydrogel is a delivery format, not proof of performance.
• The fresh-sliced mechanism must be tested as part of dose, hygiene, preservation, stability and user experience.
• Brand differentiation has to live somewhere after the novelty wears off: formula, sensory experience, ritual, evidence, pack ownership or a sharper customer job.
• For a laboratory, the best brief defines the decisions the chemist needs to solve instead of asking for a vague version of a viral object.

Sources and limits of this analysis

This article reflects the public information available on 23 September 2026 and should be updated as the products officially launch and complete ingredient information becomes available. The current reporting and product pages used for the fact check are Cosmetics Business on the three-brand packaging story, CORQ’s trend report, Fenty Skin’s product page, Glow Recipe’s product page and FDA guidance on cosmetic claims. The packaging and formulation conclusions above are technical interpretation, not confirmation of any brand’s confidential development process.